Multicenter Study
Extended evaluation of recombinant human activated protein C United States Trial (ENHANCE US): a single-arm, phase 3B, multicenter study of drotrecogin alfa (activated) in severe sepsis.
Chest. 2004 Jun 1; 125 (6): 2206-16.
Randomized Controlled Trial
Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis.
Crit. Care Med. 2003 Jan 1;31(1):12-9.
Multicenter Study
A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: comparison with a controlled clinical trial.
Crit. Care Med. 2008 Jan 1;36(1):14-23.